Evidence map›Paper›PMID 38059810›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Additively Manufactured Zn-2Mg Alloy Porous Scaffolds with Customizable Biodegradable Performance and Enhanced Osteogenic Ability.

Xuan Wang, Aobo Liu, Zhenbao Zhang, Dazhong Hao, Yijie Liang, Jiabao Dai, Xiang Jin, Huanze Deng, Yantao Zhao, Peng Wen and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xuan WangPostgraduate Training Base, Jinzhou Medical University and The Fourth Medical Centre, Chinese PLA General Hospital, Beijing, 100048, China.
Aobo LiuState Key Laboratory of Tribology in Advanced Equipment, Beijing, 100084, China.
Zhenbao ZhangDepartment of Stomatology, the Fourth Medical Centre, Chinese PLA General Hospital, Beijing, 100048, China.
Dazhong HaoState Key Laboratory of Tribology in Advanced Equipment, Beijing, 100084, China.
Yijie LiangDepartment of Stomatology, the Fourth Medical Centre, Chinese PLA General Hospital, Beijing, 100048, China.
Jiabao DaiState Key Laboratory of Tribology in Advanced Equipment, Beijing, 100084, China.
Xiang JinDepartment of Stomatology, the Fourth Medical Centre, Chinese PLA General Hospital, Beijing, 100048, China.
Huanze DengDepartment of Stomatology, the Fourth Medical Centre, Chinese PLA General Hospital, Beijing, 100048, China.
Yantao ZhaoDepartment of Stomatology, the Fourth Medical Centre, Chinese PLA General Hospital, Beijing, 100048, China.
Peng WenState Key Laboratory of Tribology in Advanced Equipment, Beijing, 100084, China.ORCID 0000-0002-5656-1988
Yanfeng LiPostgraduate Training Base, Jinzhou Medical University and The Fourth Medical Centre, Chinese PLA General Hospital, Beijing, 100048, China.

Funding

Beijing Natural Science Foundation L212066Beijing Natural Science Foundation L222110Beijing Science Nova Program 20220484155Capital clinical diagnosis and treatment technology research and transformation application project Z201100005520060Exploration project to improve the quality of standardized training for resident doctors in 2022, Health Care Project in 2022 22JSZ13Key Military Medical Projects BLB20J001National Natural Science Foundation of China 51875310National Natural Science Foundation of China 52175274National Natural Science Foundation of China 82151312National Natural Science Foundation of China 82272493PLA General Hospital New Business Support Project XYW-202110
6 · The paper itself

Abstract

The combination of bioactive Zn-2Mg alloy and additively manufactured porous scaffold is expected to achieve customizable biodegradable performance and enhanced bone regeneration. Herein, Zn-2Mg alloy scaffolds with different porosities, including 40% (G-40-2), 60% (G-60-2), and 80% (G-80-2), and different unit sizes, including 1.5 mm (G-60-1.5), 2 mm (G-60-2), and 2.5 mm (G-60-2.5), are manufactured by a triply periodic minimal surface design and a reliable laser powder bed fusion process. With the same unit size, compressive strength (CS) and elastic modulus (EM) of scaffolds substantially decrease with increasing porosities. With the same porosity, CS and EM just slightly decrease with increasing unit sizes. The weight loss after degradation increases with increasing porosities and decreasing unit sizes. In vivo tests indicate that Zn-2Mg alloy scaffolds exhibit satisfactory biocompatibility and osteogenic ability. The osteogenic ability of scaffolds is mainly determined by their physical and chemical characteristics. Scaffolds with lower porosities and smaller unit sizes show better osteogenesis due to their suitable pore size and larger surface area. The results indicate that the biodegradable performance of scaffolds can be accurately regulated on a large scale by structure design and the additively manufactured Zn-2Mg alloy scaffolds have improved osteogenic ability for treating bone defects.

Indexed as

OsteogenesisTissue ScaffoldsAlloysPorosityZincAlloysZincadditive manufacturingbiodegradable performanceosteogenic abilitystructure designZn-Mg alloy

Identifiers

PMID38059810
PMCPMC10837348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.